TRT trials should proceed with caution

Report calls for more study of testosterone replacement; urologists saybenefits are knownWashington-Clinical studies on the use of testosterone replacementtherapy (TRT) in men over age 65 years should move forward to determinethe efficacy of testosterone therapy in older men and the nature and extentof the potential benefits, according to a report released last month byan expert committee of the Institute of Medicine (IOM). Initially, studiesshould include a limited number of participants and proceed in a stepwisefashion, the report said.